Medicinal composition for treating malignant tumor accompanied with gall-stone and preparation method and medical application thereof

A technology of malignant tumor and composition, applied in the field of medicine, can solve the problems such as inability of patients to perform surgery, aggravating the burden on the liver, and harming patients.

Active Publication Date: 2014-08-27
SHIJIAZHUANG DONGFANG PHARMA
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, common gallstone treatment regimens are not suitable for patients with the above-mentioned malignant tumors accompanied by gallstones
One is that the patient itself cannot be operated on; even if the operation can be performed, it may cause more serious injuries to the patient due to the second operation
In addition, if according to the conventional medical treatment method, a large amount of choleretic and stone-removing drugs are taken at the same time as chemotherapy drugs, it will not only increase the burden on the liver, but also interact with chemotherapy drugs, affecting their respective curative effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating malignant tumor accompanied with gall-stone and preparation method and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1A pharmaceutical composition capsule

[0043] prescription:

[0044] In vitro cultured bezoar 3.44g, artificial musk 17.20g, vinegar-made Ethiopian frankincense 114.68g, vinegar-made natural myrrh 114.68g, made into 1000 capsules in total

[0045] Preparation:

[0046] 1) 3.44g of in vitro cultured bezoar and 17.20g of artificial musk were passed through an 80-mesh sieve;

[0047] 2) 114.68 g of vinegar-made Ethiopian frankincense and 114.68 g of vinegar-made natural myrrh were dried and pulverized respectively through a 60-mesh sieve;

[0048] 3) Mix the sieved crude drug obtained in step 1) and step 2) uniformly, pack into capsules, and make 1000 capsules, 0.25 g / capsule.

[0049] Dosage and usage: 6 capsules / time, 2 times / day.

Embodiment 2

[0050] Example 2 A pharmaceutical composition capsule

[0051] prescription:

[0052] In vitro cultured bezoar 2g, artificial musk 10g, vinegar-made Ethiopian frankincense 60g, vinegar-made natural myrrh 60g, made into 1000 capsules in total

[0053] Preparation:

[0054] 1) 2 g of in vitro cultured bezoar and 10 g of artificial musk are passed through an 80-mesh sieve;

[0055] 2) 60 g of vinegar-made Ethiopian frankincense and 60 g of vinegar-made natural myrrh were dried and pulverized into 60 meshes;

[0056] 3) Mix the sieved crude drug obtained in step 1) and step 2) uniformly, put into capsules, and make 1000 capsules, 0.13 g / capsule.

[0057] Dosage and usage: 8 capsules / time, 3 times / day.

Embodiment 3

[0058] Example 3 A pharmaceutical composition capsule

[0059] prescription:

[0060] In vitro cultured bezoar 4.5g, artificial musk 22.5g, vinegar-made Ethiopian frankincense 150g, vinegar-made natural myrrh 150g, made into 1000 capsules in total

[0061] Preparation:

[0062] 1) 4.5g of in vitro cultured bezoar and 22.5g of artificial musk are passed through an 80-mesh sieve;

[0063] 2) 150 g of vinegar-made Ethiopian frankincense and 150 g of vinegar-made natural myrrh were dried and pulverized into 60 meshes;

[0064] 3) Mix the sieved crude drug obtained in step 1) and step 2) uniformly, pack into capsules, and make 1000 capsules, 0.37 g / capsule.

[0065] Dosage and usage: 4 capsules / time, 2 times / day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicinal composition and a preparation method thereof. The medicinal composition consists of the following bulk pharmaceuticals in parts by weight: 2-5 parts of in-vitro-cultured calculus bovis, 10-25 parts of synthetic musk, 60-170 parts of frankincense processed with vinegar and 60-170 parts of myrrh processed with vinegar. The invention further provides an application of the medicinal composition to preparation of a medicament for treating malignant tumor accompanied with gall-stone. As proved by clinical test, the medicinal composition has a remarkable curative effect on gall-stone accompanied with malignant tumor, and can be used for relieving tumor symptoms.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition for malignant tumor with gallstones, its preparation method and medical application. Background technique [0002] Xihuang Pills, also known as Xihuang Pills, come from the "Surgical Quansheng Collection" by Wang Hongxu, a famous physician in the Qing Dynasty, and are composed of musk, bezoar, myrrh (made), and frankincense (made). The drug has been developed into pharmaceutical preparations for clinical application, such as Xihuang Pills and Xihuang Capsules. At present, it is clinically used for the treatment or adjuvant treatment of toxins and blood stasis, carbuncle sores, genital gangrene swelling and pain, multiple abscesses, lymphadenitis, and cold abscesses belonging to the above syndromes, as well as malignant tumors and postoperative malignant tumors. [0003] Due to the limitation of the sources of medicinal materials, artificial bezoar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/328A61P35/00A61P1/16A61K35/413A61K35/32
Inventor 马旭伟赵环韩丰年李召红
Owner SHIJIAZHUANG DONGFANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap